Sharemaestro Newsreel

Enel (BIT:ENEL) Stock Looks Reasonable After Its 82% Three Year Run

Enel has delivered a powerful multi‑year share price run, and that raises a straightforward question for investors who care about earnings. Is the current valuation still grounded in what the business is actually earning today? Over the past 3 years the stock has gained …

Kesko Oyj (HLSE:KESKOB) After August Sales Growth Is The Stock Fully Valued

Kesko Oyj (HLSE:KESKOB) reported August 2026 Group sales of €1,165.0m, a 5.4% increase, with year to date revenue of €8,841.3m. Traders are watching how this fresh data filters into valuation views. That sales beat aligns with a share price that has picked up momentum, …

Kesko (HLSE:KESKOB) Stock May Be Trading At A Premium On Earnings

Kesko Oyj has delivered a 58.4% share price gain over the past 3 years, which puts a bright spotlight on what investors are currently paying for its earnings. With the stock last closing at €22.98, the key issue is whether that price lines up …

Alten (ENXTPA:ATE) Stock May Still Offer Value On Earnings Strength

Alten has seen its share price move around in recent years, and that naturally puts the focus on whether today's valuation is supported by the consulting group's earnings power. With investors watching both recent setbacks and shorter term rebounds, the question now is how …

3 Stocks Tied To Apple And Nvidia Supply Chain Demand

Market leadership has rarely felt this concentrated, with Apple and Nvidia together now carrying more than 15% of the S&P 500 and pulling a tight circle of suppliers into the spotlight. That kind of focus can magnify both upside and risk, which is exactly …

Alten (ENXTPA:ATE) Could Be 26% Undervalued On Its Latest Valuation Read

Alten (ENXTPA:ATE) has drawn fresh attention after a recent price move, with the shares closing at €70.8. Investors now have updated return figures to reassess the engineering and IT consultancy's profile. The recent pullback, with a 1-day share price return down 2.48%, comes after …

Failure of Novartis’ Pelacarsen Could Reshape the Lp(a) Race for CRISPR and Ionis

Novartis AG's (NYSE:NVS) Phase 3 Lp(a)HORIZON setback carries implications beyond the Swiss drugmaker. Pelacarsen significantly lowered lipoprotein(a), or Lp(a), but failed to produce a statistically significant reduction in major cardiovascular events, according to the information provided. READ ALSO: Can a Tagrisso Combination Strengthen AstraZeneca's …

Marie Brizard Wine & Spirits: First Half 2026 earnings

Marie Brizard Wine & Spirits Charenton-le-Pont, 24th September 2026 H1 2026 earnings H1 2026 earnings down amid a globally challenging market environment Business resilience in France, particularly in the second quarter EBITDA1 of €4.9m in H1 2026, down €0.9m from €5.9m in H1 2025 …

European Markets Close Lower in Thursday Trading as Bond Yields, Oil Prices Rise

The European stock markets closed lower in Thursday trading as bond yields and oil prices surged whi PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade …

TP Appoints Benoit Gabelle as Group Chief Financial Officer

PARIS, September 24, 2026--(BUSINESS WIRE)--Regulatory News: TP (Paris:TEP), a global leader in digital business services, today announced the appointment of Benoit Gabelle as Group Chief Financial Officer, effective immediately. Benoit Gabelle has served as Interim Group Chief Financial Officer since March 2026 when Jorge …

European Cybersecurity Stocks Gaining Attention As Nato Threats Put Critical Networks In Focus

European security risk has moved from theory to front page as Danish intelligence warns that a Russian move against a Nato country is possible within months, and that raises the stakes for anything tied to critical infrastructure and cybersecurity. Hybrid threats like cyber intrusions …

Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth?

Recursion Pharmaceuticals RXRX continues to leverage its AI-native drug discovery platform through a broad portfolio of pharma, technology and data partnerships. These collaborations are expanding its pipeline while generating non-dilutive funding to support R&D. As of the second quarter of 2026, RXRX had received …

Chronic Kidney Disease Market: 5 Emerging Therapies to Watch as the Treatment Landscape Expected to Evolve by 2036 | DelveInsight

A diversified late-stage pipeline encompassing endothelin receptor antagonists, aldosterone synthase inhibitors such as lorundrostat, APOL1 inhibitors including MZE829, and cell therapy approaches such as rilparencel is poised to intensify competition, with each modality addressing mechanisms that complement the established SGLT2 inhibitor/MRA backbone. The CKD …

Will Vertex's Kidney Disease Pipeline Be a New Growth Engine?

Vertex Pharmaceuticals Incorporated VRTX has established a dominant position in the cystic fibrosis (CF) market through its portfolio of CFTR modulators, including Trikafta/Kaftrio and the newer Alyftrek. Vertex's marketed CF therapies are currently used by nearly three-quarters of the approximately 97,000 people with CF …

3 British Defensive Stocks With ROE Over 27%

Soaring global bond yields, driven in part by rising oil prices and higher interest rate expectations, have pushed many investors towards solid, lower risk anchors in their portfolios. For British shares, that puts extra attention on companies with strong balance sheets and resilient cash …

GoComet launches Nova, an AI-native execution layer for enterprise logistics, at Odyssey Singapore

Leaders from OpenAI, Olam Agri and GoComet joined senior supply chain executives to examine how AI can take on more of the operational work behind global trade. SINGAPORE, Sept. 24, 2026 /PRNewswire/ -- Last week at Odyssey, its flagship gathering of the leaders who …

EnBW (XTRA:EBK) Stock Could Be 35% Overvalued As Fast Charging Expands

EnBW Energie Baden-Württemberg has spent years reshaping its energy and charging infrastructure footprint, while the share price has only inched ahead over longer periods. That mix puts the spotlight squarely on one issue for EnBW stock today: whether the current price is supported by …

SES Appoints Michel Scholer to Board of Directors

Michel brings extensive leadership, governance and strategic policy experience through his roles with the Luxembourg government LUXEMBOURG, September 23, 2026--(BUSINESS WIRE)--SES today announced the appointment of Mr. Michel Scholer, Secretary General of the Luxembourg Government and Chief of Staff to the Prime Minister, to …

SES Confirms Interim Dividend of EUR 0.25

Interim dividend approved as part of SES's continued commitment to shareholder returns intended to be at least EUR 0.50 total dividend for FY2026 LUXEMBOURG, September 23, 2026--(BUSINESS WIRE)--The SES Board of Directors has approved the payment of an interim dividend of EUR 0.25 per …

In a challenging environment, Synergie confirms the resilience of its business model and the strength of its growth strategy

SYNERGIE Press Release | September 23rd, 2026 – 5.45pm IN A CHALLENGING ENVIRONMENT, SYNERGIE CONFIRMS THE RESILIENCE OF ITS BUSINESS MODEL AND THE STRENGTH OF ITS GROWTH STRATEGY Revenue : €1,710.5 million EBITDA : €61.4 million Net Profit : €24.5 million On September 23rd, …

3 European Utility Stocks To Watch As Grid Spending And Regulation Collide

Capitalize on Breakthrough Therapy Designation Shifts: Benchmark Pfizer, Roche, Novartis, Merck and AstraZeneca to Accelerate Approvals, Defend Pipeline ROI and Capture Revenue

Company Logo Expedited FDA pathways are boosting oncology and rare-disease drug development, with gene therapy, immunotherapy and precision medicine creating key opportunities. Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Breakthrough Therapy (BT) Designation - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. …

SOL (BIT:SOL) Climbed After Its Latest Update, What Is Catching Attention?

SOL S.p.A. (BIT:SOL) released half year 2026 results, reporting sales of €948.55 million and total revenue of €962.69 million, alongside net income of €89.87 million and earnings per share of €0.991. The earnings release appears to have fed into positive sentiment around SOL, with …

3 Integrated Oil And Gas Stocks Tied To Iran Supply Risk

Geopolitics around Iran have moved from background noise to front-page risk, and that shift is rippling through global integrated oil and gas producers. When conflict risk, energy supply questions and election politics collide, pricing for crude and related stocks can swing hard, creating both …

Colruyt Group (ENXTBR:COLR) Confirms Annual Dividend, Is The Stock Cheap Or Pricey?

Colruyt Group (ENXTBR:COLR) has confirmed an annual dividend of €0.9660 per share, with the payout scheduled for 6 October 2026, following an ex-dividend date of 2 October and a record date of 5 October. The confirmed payout lands while Colruyt Group's share price has …

Creatio Invests $300 Million in Its Bank.AI Platform to Drive AI Adoption in Financial Services

BOSTON, Sept. 22, 2026 /PRNewswire/ -- Creatio, an AI CRM and workflow platform where people and AI agents work together, today announced a $300 million investment from 2026 through 2028 in Creatio Bank.AI, its market-leading offering for banks and financial institutions. The investment comes …

Spain Heatwave Puts Solaria Stock In Focus For Climate Adaptation Investors

Spain's record heat, wildfires, and drought are no longer distant headlines. They are starting to reshape where capital feels safe and where it looks more exposed. That shift creates a live question for your portfolio: Which Spanish stocks could benefit from climate adaptation spending, …

3 European Energy Stocks Linked To Non Russian Crude Routes

Russia's election result and the latest drone strikes on major oil infrastructure have pushed energy security back onto the front page, and that matters for any stock even loosely tied to fuel supply chains. Disruption risk in Russia can shift attention toward European refiners …

How Is AES Corporation's Stock Performance Compared to Other Utility Stocks

Close up of AES sign on the building at AES's US clean energy business headquarters in Salt lake City, UT, USA, June 26, 2023_ AES is a clean energy developer_ See Less Arlington, Virginia-based The AES Corporation (AES) operates as a power generation and …

Capitalize on the Orphan Drug Revenue Shift: Benchmark Novartis, Roche, Pfizer, Sanofi and AstraZeneca to Secure High-Value Growth Before Rivals Move First

Company Logo Orphan drug demand is rising as genomics, biologics and personalized therapies advance, aided by faster approvals, government incentives, advocacy and improved rare-disease diagnosis. Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Orphan Drugs - Global Strategic Business Report" has been added to ResearchAndMarkets.com's …

BoomRay Enters Exclusive Global License Agreement with Novartis for a Novel Radioligand Therapy Asset

SUZHOU, China, Sept. 22, 2026 /PRNewswire/ -- Boomray Pharmaceuticals Co., Ltd. ("BoomRay"), a clinical-stage biotechnology company pioneering innovative radioligand therapies (RLTs) for precision oncology diagnostics and therapeutics, today announced that it has entered into an exclusive global license agreement with Novartis Pharma AG ("Novartis") …

Novartis (NVS) Faces Another Pipeline Setback as ALS Drug Fails Mid-Stage Trial

Novartis AG (NYSE:NVS) has discontinued development of VHB937, also known as lifonebart, after the experimental ALS drug failed to meet both its primary and secondary endpoints in a Phase II trial involving 251 patients with early-stage ALS. The drug targeted TREM2, a protein involved …

Buzzi (BIT:BZU) Looks Undervalued On Paper, Is The Pullback A Bargain?

Recent trading in Buzzi (BIT:BZU) has drawn attention after a period of mixed share performance, with the stock down over the past week, month and past three months, despite a positive three-year and five-year total return record. Buzzi's recent 30-day share price return, down …

Is Brilliance China Automotive Holdings (SEHK:1114) Cheap Following Its FTSE All World Index Exit?

Brilliance China Automotive Holdings (SEHK:1114) has been removed from the FTSE All-World Index (USD), an index change that can spur forced trading as passive funds adjust their holdings. Recent trading has been volatile. The share price return over the past month is down 25.57%, …

NVS Gets Positive CHMP Opinion for Cosentyx for Another Indication

Novartis NVS announced that the Committee for Medicinal Products for Human Use ("CHMP") of the European Medicines Agency ("EMA") has issued a positive opinion recommending marketing authorization for an additional indication of its arthritis drug Cosentyx (secukinumab). The CHMP recommended Cosentyx for the treatment …

Novo Sets Long-Term Targets Ahead of Semaglutide Patent Expirations

Novo Nordisk's (NVO) US-listed shares declined as the Danish drugmaker unveiled its long-term growth PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a …